JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4526
iShares MSCI USA Equal Weighted ETF
EUSA
$1.9B
| $173K | ﹤0.01% |
2,936
-514
| -15% | -$29.9K |
2018 Q2
4 quarters
|
|
|
BKS
4527
DELISTED
Barnes & Noble
BKS
| $173K | ﹤0.01% |
25,955
+4,005
| +18% | +$21.8K |
2013 Q2
24 quarters
|
|
|
ESTE
4528
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $173K | ﹤0.01% |
28,409
+23,803
| +517% | +$156K |
2017 Q4
6 quarters
|
|
4529
Virtus Biotech ETF
BBP
$129M
| $172K | ﹤0.01% |
4,260
+843
| +25% | +$34.7K |
2017 Q1
9 quarters
|
|
4530
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.2B
| $171K | ﹤0.01% |
4,266
+1,630
| +62% | +$64.8K |
2018 Q3
3 quarters
|
|
|
PSDO
4531
DELISTED
Presidio, Inc. Common Stock
PSDO
| $171K | ﹤0.01% |
12,668
-3,245
| -20% | -$45.7K |
2017 Q4
6 quarters
|
|
4532
Axsome Therapeutics
AXSM
$9.28B
| $170K | ﹤0.01% |
+6,689
| New | +$134K |
2019 Q2
0 quarters
|
|
4533
WisdomTree International Equity Fund
DWM
$655M
| $170K | ﹤0.01% |
3,340
+1,238
| +59% | +$63K |
2015 Q4
14 quarters
|
|
4534
UroGen Pharma
URGN
$2.09B
| $170K | ﹤0.01% |
+5,146
| New | +$190K |
2019 Q2
0 quarters
|
|
|
PRTY
4535
DELISTED
Party City Holdco Inc.
PRTY
| $170K | ﹤0.01% |
23,504
+2,804
| +14% | +$21.4K |
2016 Q4
10 quarters
|
|
4536
ACM Research
ACMR
$5.31B
| $169K | ﹤0.01% |
32,850
+26,730
| +437% | +$155K |
2018 Q2
4 quarters
|
|
|
ANH
4537
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $169K | ﹤0.01% |
46,242
-9,802
| -17% | -$39.4K |
2013 Q2
24 quarters
|
|
|
AXDX
4538
DELISTED
Accelerate Diagnostics
AXDX
| $167K | ﹤0.01% |
749
+113
| +18% | +$22.1K |
2017 Q4
6 quarters
|
|
4539
St. Joe Company
JOE
$3.77B
| $167K | ﹤0.01% |
9,959
+785
| +9% | +$13.2K |
2013 Q2
24 quarters
|
|
4540
Dorian LPG
LPG
$2.47B
| $167K | ﹤0.01% |
18,759
-245,107
| -93% | -$1.95M |
2016 Q4
10 quarters
|
|
4541
Amplify Alternative Harvest ETF
MJ
$102M
| $167K | ﹤0.01% |
438
-1,588
| -78% | -$641K |
2018 Q1
5 quarters
|
|
|
IBML
4542
DELISTED
iShares iBonds Dec 2023 Term Muni Bond ETF
IBML
| $167K | ﹤0.01% |
6,475
| – | – |
2017 Q2
8 quarters
|
|
4543
Invesco Zacks Mid-Cap ETF
CZA
$171M
| $166K | ﹤0.01% |
2,348
+257
| +12% | +$17.9K |
2016 Q4
10 quarters
|
|
4544
Horizon Bancorp
HBNC
$988M
| $166K | ﹤0.01% |
10,252
+1,218
| +13% | +$19.7K |
2017 Q4
6 quarters
|
|
4545
Companhia Siderúrgica Nacional
SID
$1.64B
| $166K | ﹤0.01% |
39,047
-1,692,296
| -98% | -$6.81M |
2018 Q2
4 quarters
|
|
|
STML
4546
DELISTED
Stemline Therapeutics, Inc.
STML
| $166K | ﹤0.01% |
11,004
+1,715
| +18% | +$24.8K |
2017 Q3
7 quarters
|
|
4547
ARK Innovation ETF
ARKK
$8.25B
| $165K | ﹤0.01% |
3,598
+231
| +7% | +$10.5K |
2019 Q1
1 quarter
|
|
4548
National Bankshares
NKSH
$274M
| $165K | ﹤0.01% |
4,412
-133
| -3% | -$5.3K |
2017 Q4
6 quarters
|
|
4549
American Vanguard Corp
AVD
$50.7M
| $164K | ﹤0.01% |
10,913
+1,529
| +16% | +$23.3K |
2013 Q2
24 quarters
|
|
|
COOP
4550
DELISTED
Mr. Cooper
COOP
| $164K | ﹤0.01% |
20,907
+2,753
| +15% | +$23.2K |
2015 Q4
14 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.